STOCK TITAN

Planned sale of 20,000 shares by Company insider (Nasdaq: DRTS)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of ordinary shares of DRTS has filed a notice of proposed sale under Rule 144. The filing states an intention to sell 20,000 ordinary shares through Oppenheimer & Co. Inc. on the Nasdaq market, with an aggregate market value of $118,000. These shares are part of 70,000 restricted stock units (RSUs) that were acquired from the issuer on 08/08/2021. The notice also reports that there were 70,380,570 shares of this class outstanding, providing a sense of the company’s total equity base.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the DRTS Form 144 filing disclose?

The Form 144 discloses that a holder of DRTS ordinary shares plans to sell 20,000 shares on Nasdaq through Oppenheimer & Co. Inc. with an aggregate market value of $118,000.

How many DRTS shares are planned to be sold under this Form 144?

The notice indicates an intended sale of 20,000 ordinary shares of DRTS.

What is the approximate market value of the DRTS shares to be sold?

The Form 144 lists an aggregate market value of $118,000 for the 20,000 ordinary shares proposed to be sold.

When were the DRTS shares to be sold originally acquired?

The securities to be sold come from RSUs that were acquired from the issuer on 08/08/2021, in an amount of 70,000 securities.

Which broker is handling the planned DRTS share sale?

The filing identifies Oppenheimer & Co. Inc., located at Broad 85 St., New York, NY 10004, as the broker for the proposed sale on Nasdaq.

How many DRTS shares of this class were outstanding?

For context, the Form 144 reports 70,380,570 ordinary shares of this class as outstanding.

When is the approximate date of the planned DRTS share sale?

The filing lists an approximate date of sale of 01/08/2026 for the proposed transaction.
Alpha Tau Medical Ltd

NASDAQ:DRTS

DRTS Rankings

DRTS Latest News

DRTS Latest SEC Filings

DRTS Stock Data

611.34M
57.38M
32.79%
2.28%
0.11%
Biotechnology
Healthcare
Link
Israel
Jerusalem